Of all people living on the planet today, there are an estimated 2 billion who do not have access to essential medicines and vaccines. Most of them live in low- and middle-income countries. While scientific breakthroughs are leading to the development of new medicines to treat or cure many diseases, these fail to reach everyone who needs them. Even medicines that have been known for a long time are hard to get a hold of in certain parts of the world. This is called the access-to-medicine issue. In this article, Thomas and Jayasree explore four distinct approaches where pharmaceutical companies can improve their efforts on this issue, namely: availability, accessibility, affordability and acceptability.
Read the full article on Frontiers for Young Minds.